Prevalence and genotyping of HPV in cervical cancer among Australian women

被引:18
作者
Chen, S [1 ]
O'Sullivan, H
Tabrizi, SN
Fairley, CK
Quinn, MA
Garland, SM
机构
[1] Royal Hosp Women, Dept Microbiol & Infect Dis, Carlton, Vic, Australia
[2] Royal Hosp Women, Dept Oncol, Carlton, Vic, Australia
[3] Monash Univ, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia
关键词
cervical cancer; HPV; tumor histology;
D O I
10.1016/S0020-7292(99)00167-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the association between HPV DNA detection and histological examination of tumor biopsies from women with cervical cancer. Method: A total of 186 women with cervical cancer were screened for HPV infection using MY09/MY11 primer based PCR. The status of HPV infection was correlated with histological and demographic characteristics by Fisher's exact test or Chi square test. Result: The prevalence of HPV infection in this Australian population was 91.9% (171). Among these 53.8% (100) were HPV type 16, 17.2% (32) HPV type 18, and 21.0% (39) other HPV types. Three significant associations were identified: (1) HPV genotype Is and adenocarcinomas/adenosquamous carcinomas (P < 0.001); (2) HPV DNA negativity and postmenopausal status (P = 0.02); and (3) HPV DNA positivity and lymphocyte infiltration of tumor tissues (P = 0.03). Conclusion: HPV infection is present in the vast majority of cervical cancer patients. However, its presence or genotyping does not seem to have a major influence on the pathogenesis of cervical cancer, such as tumor grade, FIGO staging and metastasis (P > 0.1). (C) 1999 International Federation of Gynecology and Obstetrics.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 30 条
[1]  
*AUSTR I HLTH WELF, 1998, AUSTR I HLTH WELF AS
[2]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]  
Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt
[5]  
546::AID-IJC9&gt
[6]  
3.0.CO
[7]  
2-T
[8]  
CONDON J, 1996, CANC N TERRITORY
[9]   HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN CERVICAL SMEARS AS PREDICTOR OF HIGH-GRADE CERVICAL-CANCER [J].
CUZICK, J ;
TERRY, G ;
HO, L ;
HOLLINGWORTH, T ;
ANDERSON, M .
LANCET, 1992, 339 (8799) :959-960
[10]  
FRANCO EL, 1992, CANCER EPIDEM BIOMAR, V1, P499